Jiande Chen, PhD

Division of Gastroenterology and Hepatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA

Dr. Chen received his graduate education at the Catholic University of Leuven in Belgium. While there he started his research on gastrointestinal motility with a group of internationally renowned investigators in the Department of Medicine. Upon completing his PhD in 1989, Dr. Chen moved to the United State where he accepted a faculty position at the University of Virginia School of Medicine. In June 1999, he joined the Division of Gastroenterology, Department of Internal Medicine at University of Texas Medical Branch as a Professor and served as Director of Clinical Physiology Lab.

Currently, Dr. Chen is Professor of Medicine in the Division of Gastroenterology and Hepatology at Department of Medicine and Department of Biomedical Engineering at Johns Hopkins University and Director of Clinical Gastrointestinal Motility Lab.

Dr. Chen has received more than 100 research grants from various government and state agents, such as National Institutes of Health, Veterans Administration, Department of Defense and industries. Dr. Chen has trained more than 100 doctoral students, post-docs and young scholars, filed more than 30 US patents and published more than 400 peer-reviewed papers in leading SCI journals.

Dr. Chen served as the first President of International Electrogastrography Society and is currently the Vice President of International Gastrointestinal Electrophysiology Society. He served as a council member of American Neurogastroenterology and Motility and board member of North American Neuromodulation Society. He was Associate Editor of Neuromodulation and serves on editorial board for a dozen of international peer-reviewed professional journals.

Dr. Chen’s current research interest is in the area of neuromodulation and its applications for treating obesity, diabetes and functional gastrointestinal diseases and inflammatory bowel diseases. Examples of his research projects include functional gastrointestinal diseases; gastric electrical stimulation for obesity; intestinal electrical stimulation for diabetes; spinal cord stimulation for functional gastrointestinal diseases; vagal nerve stimulation for obesity and sacral nerve stimulation for inflammation.

Terms of Appointment: Oct 2019 – Sep 2021